Literature DB >> 17465357

Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.

William H Slattery1, Laurel M Fisher, William Hitselberger, Rick A Friedman, Derald E Brackmann.   

Abstract

OBJECT: The authors reviewed the proportion of pediatric patients with neurofibromatosis Type 2 (NF2) in whom hearing was preserved after middle fossa resection of vestibular schwannoma (VS).
METHODS: In this retrospective chart review the authors examined the cases of 35 children with NF2 who had undergone middle fossa resection (47 surgeries) between 1992 and 2004 in a neurotological tertiary care center. Surgical outcome was assessed using pure-tone average (PTA) thresholds obtained before and immediately after resection. Speech discrimination scores (SDSs) and pre- and postfacial nerve grades were also recorded. In 55% of surgeries, hearing of less than or equal to 70 dB PTA was maintained postoperatively. The American Academy of Otolaryngology-Head and Neck Surgery Class A hearing (PTA < or = 30 dB and SDS > or = 70%) was preserved in 47.7%. Facial nerve function was good (House-Brackmann Grades I or II) in 81% of the patients. Twelve patients had bilateral middle fossa resections; in nine (75%) of these patients hearing was maintained postoperatively in both ears.
CONCLUSIONS: More than half of the children with NF2 in the authors' cohort experienced hearing preservation after middle fossa resection was performed for VS. The authors recommend this approach for preserving hearing in children with NF2.

Entities:  

Mesh:

Year:  2007        PMID: 17465357     DOI: 10.3171/ped.2007.106.4.255

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

Authors:  Jaishri O Blakeley; D Gareth Evans; John Adler; Derald Brackmann; Ruihong Chen; Rosalie E Ferner; C Oliver Hanemann; Gordon Harris; Susan M Huson; Abraham Jacob; Michel Kalamarides; Matthias A Karajannis; Bruce R Korf; Victor-Felix Mautner; Andrea I McClatchey; Harry Miao; Scott R Plotkin; William Slattery; Anat O Stemmer-Rachamimov; D Bradley Welling; Patrick Y Wen; Brigitte Widemann; Kim Hunter-Schaedle; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2011-12-02       Impact factor: 2.802

2.  Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.

Authors:  Nicolas -Xavier Bonne; Rabih Aboukais; Marc Baroncini; Audrey Hochart; Pierre Leblond; Franck Broly; Frédérique Dubrulle; Jean-Paul Lejeune; Christophe Vincent
Journal:  Childs Nerv Syst       Date:  2016-10-04       Impact factor: 1.475

3.  Options and strategies for hearing restoration in pediatric neurofibromatosis type 2.

Authors:  Hossein Mahboubi; William H Slattery; Gautam U Mehta; Gregory P Lekovic
Journal:  Childs Nerv Syst       Date:  2020-06-21       Impact factor: 1.475

4.  Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.

Authors:  Fu Zhao; Bo Wang; Zhijun Yang; Qiangyi Zhou; Peng Li; Xingchao Wang; Jing Zhang; Junting Zhang; Pinan Liu
Journal:  J Neurooncol       Date:  2018-02-28       Impact factor: 4.130

Review 5.  Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma.

Authors:  Jaishri Blakeley
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2012-10       Impact factor: 2.064

6.  Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2.

Authors:  Shi-Wei Li; Jing Zhang; Han-Lu Tang; Peng Li; Bo Wang; Fu Zhao; Pi-Nan Liu
Journal:  J Neurooncol       Date:  2021-11-09       Impact factor: 4.130

7.  Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges.

Authors:  Byung Sup Kim; Ho Jun Seol; Jung-Il Lee; Hyung Jin Shin; Kwan Park; Doo-Sik Kong; Do-Hyun Nam; Yang-Sun Cho
Journal:  Neurosurg Rev       Date:  2016-05-04       Impact factor: 3.042

Review 8.  Genetic causes of cancer predisposition in children and adolescents.

Authors:  Federica Saletta; Luciano Dalla Pozza; Jennifer A Byrne
Journal:  Transl Pediatr       Date:  2015-04

Review 9.  Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge.

Authors:  Steffen Rosahl; Christopher Bohr; Michael Lell; Klaus Hamm; Heinrich Iro
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

Review 10.  The Neurofibromatoses.

Authors:  Said Farschtschi; Victor-Felix Mautner; Anna Cecilia Lawson McLean; Alexander Schulz; Reinhard E Friedrich; Steffen K Rosahl
Journal:  Dtsch Arztebl Int       Date:  2020-05-15       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.